Reply to: Laffon and Marthan “FDG PET for therapy monitoring in Hodgkin’s and non-Hodgkin’s lymphomas: qPET versus rPET”
Crossref DOI link: https://doi.org/10.1007/s00259-017-3826-x
Published Online: 2017-09-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kluge, Regine http://orcid.org/0000-0003-1245-1290
Barrington, Sally
Kurch, Lars
Hasenclever, Dirk
License valid from 2017-09-22